Researchers develop ‘highly sensitive’ breast cancer blood test
Researchers found that the test was able to identify circulating tumour DNA in every patient before they started treatment.
Read More
Tag: TARDIS
- NICE backs daratumumab quadruplet for newly diagnosed transplant‑ineligible myeloma
- Anocca doses first patients with precision TCR‑T therapy
- Connecta launches phase 2a trial of neuroplasticity modulator
- Aquipta recommended by NICE for acute migraine treatment
- Talvey accepted for use in Scotland for relapsed and refractory multiple myeloma
